Klinique Medical Clinic Public Co. Ltd.

As of June 30, 2026, Klinique Medical Clinic Public Co. Ltd. carries a market capitalization of 5.89B, placing it among publicly traded companies globally. Its enterprise value stands at 5.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Klinique Medical Clinic Public Co. Ltd.'s next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, Klinique Medical Clinic Public Co. Ltd. has 220.00M shares outstanding.

As of June 30, 2026, Klinique Medical Clinic Public Co. Ltd. trades at a trailing price-to-earnings ratio of 13.90. The price-to-sales ratio is 1.43, and the price-to-book ratio stands at 3.20.

As of June 30, 2026, Klinique Medical Clinic Public Co. Ltd. trades at an EV/EBITDA multiple of 6.23 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.40 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 10.26 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Klinique Medical Clinic Public Co. Ltd. trades at an EV/FCF ratio of 11.57, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 5.73B versus a market cap of 5.89B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Klinique Medical Clinic Public Co. Ltd. maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 34.97, indicating elevated leverage, while an interest coverage ratio of 33.77 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Klinique Medical Clinic Public Co. Ltd. posted a return on equity (ROE) of 23.60, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 17.50 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 12.72, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 18.08, useful for judging operating efficiency across full business cycles. The company generates approximately 6.62M in revenue per employee across its workforce of 620.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.70 indicates how many times Klinique Medical Clinic Public Co. Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Klinique Medical Clinic Public Co. Ltd. recorded 115.89M in income tax expense. That works out to an effective tax rate of 21.51, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 538.65M, leaving 422.30M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Klinique Medical Clinic Public Co. Ltd.'s stock has gained approximately 31.37% over the past 52 weeks. The 50-day moving average sits at 29.43, while the 200-day moving average is 26.27.

Over the twelve months ended June 30, 2026, Klinique Medical Clinic Public Co. Ltd. generated 4.10B in revenue and converted that into 422.30M in net income, yielding earnings per share of 1.93. EBITDA reached 919.32M, while operating income came in at 558.46M.

As of June 30, 2026, Klinique Medical Clinic Public Co. Ltd. holds 811.45M in cash and equivalents against 646.79M in total debt, resulting in a net debt position of -427.68M. Total book value stands at 1.84B, with working capital of 257.52M providing operational flexibility.

Klinique Medical Clinic Public Co. Ltd. produced 748.96M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -275.22M in capital expenditures, free cash flow totaled 473.74M - equivalent to 2.16 per share.

Over the twelve months ended June 30, 2026, Klinique Medical Clinic Public Co. Ltd. posted a gross margin of 50.88, reflecting its pricing power and cost economics. The operating margin of 13.61 and net profit margin of 10.29 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Klinique Medical Clinic Public Co. Ltd. paid dividends of 0.70 per share. The dividend payout ratio of 36.39 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 8.07, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 7.99, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Klinique Medical Clinic Public Co. Ltd. shareholders.

As of June 30, 2026, Klinique Medical Clinic Public Co. Ltd. has an Altman Z-Score of 4.14, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.